Beyond chemotherapy: proapoptotic and antiangiogenic drug effects in preclinical ovarian cancer models
PhD ceremony: Mr. A.R.M. van der Bilt, 14.30 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Beyond chemotherapy: proapoptotic and antiangiogenic drug effects in preclinical ovarian cancer models
Promotor(s): prof. E.G.E. de Vries, prof. A.G.J. van der Zee, prof. S. de Jong
Faculty: Medical Sciences
Standard therapy for ovarian cancer, consisting of platinum-based chemotherapy and surgical debulking, has been unchanged since its introduction over a decade ago. Other chemotherapeutic regimens did not improve the poor prognosis of advanced ovarian cancer patients. Alternative therapeutic strategies are therefore being pursued, by applying molecular targeted drugs. These drugs interfere with key biological processes relevant to ovarian cancer biology, amongst which are the potential of these cancers to evade programmed cell death (apoptosis) and to create a vascular supply (angiogenesis). In this thesis the effects of proapoptotic and anti-angiogenic targeted drugs was investigated in preclinical ovarian cancer models.
Last modified: | 13 March 2020 01.01 a.m. |
More news
-
04 July 2025
University of Groningen awards various prizes during Ceremony of Merits
The UG awarded different prizes to excellent researchers and students during the Ceremony of Merits on 4 July 2025.
-
02 July 2025
Relinde Weil reappointed as a member of the Supervisory Board UG
The Minister of Education has reappointed Relinde Weil for a second term as a member of the Supervisory Board of the University of Groningen.